Prescient Therapeutics Ltd (ptx) Logo

Prescient Therapeutics Ltd (PTX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

PTX ASX Chart

Snapshot

Prescient Therapeutics (PTX) are focused on developing novel, personalized therapies for a range of cancers. Prescient has a broad pipeline of personalized cancer treatments, comprising CAR-T and targeted therapies, for a range of different cancers. The Company has licensed technologies from and in collaboration with world-leading cancer centers in the US and Australia.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -72.41%
vs ASX 200 (1yr) -74.23%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,323 of 2,357
Sector Rank 121 of 230

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ATX / CC5 / ILA
EPS -$0.01
DPS $0.00
Book Value Per Share $0.02

Broker Consensus

PTX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office South Melbourne VIC 3205
Website www.ptxtherapeutics.com
Registry Automic Group
Auditor William Buck Audit (VIC) Pty Ltd
Date Listed 19 Dec 1986

Upcoming Calendar (Forecasted)

Date Event
21/02/2025 Report (Interim)
25/08/2025 Report (Prelim)
25/08/2025 Report (Annual)

Former Company Names

  • Rancoo Ltd (RAN), 24/03/1997. Virax Holdings Limited (VHL), 12/12/2014,

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PTX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
30/09/24 Gavin Shepherd Buy +235,908 $0.04 $9,435 On-market trade
01/05/23 James Campbell Issued 136,231 $0.098 $13,350 Exercise of options
01/05/23 James Campbell Exercise 278,769 $0.098 $27,319 Exercise of options
01/05/23 Steven (Steve) Engle Issued 219,939 $0.098 $21,554 Exercise of options
01/05/23 Steven (Steve) Engle Exercise 450,061 $0.098 $44,105 Exercise of options
01/05/23 Steven Yatomi-Clarke Issued 1,148,936 $0.098 $112,595 Exercise of options
01/05/23 Steven Yatomi-Clarke Exercise 2,351,064 $0.098 $230,404 Exercise of options
04/04/23 James Campbell Buy +17,813 $0.062 $1,113 Exercise of options
04/04/23 James Campbell Exercise 17,813 $0.062 $1,113 Exercise of options
04/04/23 Steven Yatomi-Clarke Buy +97,692 $0.062 $6,105 Exercise of options
04/04/23 Steven Yatomi-Clarke Exercise 97,692 $0.062 $6,105 Exercise of options
14/12/22 Steven Yatomi-Clarke Issued 641,711 $0.135 $86,630 Exercise of options
14/12/22 Steven Yatomi-Clarke Exercise 2,000,000 $0.135 $270,000 Exercise of options
11/10/22 James Campbell Issued 28,571 $0.175 $5,000 Participation in share purchase plan
11/10/22 Steven Yatomi-Clarke Issued 171,428 $0.175 $30,000 Participation in share purchase plan
10/12/20 Allen Ebens Issued 1,000,000 $0.064 $64,000 Issue of options
10/12/20 James Campbell Issued 1,000,000 $0.064 $64,000 Issue of options
10/12/20 Steven Yatomi-Clarke Issued 12,900,000 $0.064 $825,600 Issue of options
10/12/20 Steven (Steve) Engle Issued 2,100,000 $0.064 $134,400 Issue of options
24/08/20 Steven Yatomi-Clarke Issued 545,455 $0.055 $30,000 Participation in share purchase plan
02/05/19 Steven (Steve) Engle Issued 670,000 $0.047 $31,490 Issue of options
02/05/19 Paul Hopper Issued 415,000 $0.047 $19,505 Issue of options
02/05/19 James Campbell Issued 415,000 $0.047 $19,505 Issue of options
02/05/19 Steven Yatomi-Clarke Issued 3,500,000 $0.047 $164,500 Issue of options
30/04/19 Paul Hopper Issued 103,814 $0.042 $4,360 Prospectus
30/04/19 James Campbell Issued 17,813 $0.042 $748 Prospectus
30/04/19 Steven Yatomi-Clarke Issued 97,692 $0.042 $4,103 Prospectus
30/04/19 Steven Yatomi-Clarke Buy +195,383 $0.05 $9,769 Prospectus
30/04/19 James Campbell Buy +35,625 $0.05 $1,781 Prospectus
30/04/19 Paul Hopper Buy +207,628 $0.05 $10,381 Prospectus
26/03/19 James Campbell Buy +178,125 $0.056 $9,968 On-market trade
18/12/18 Steven Yatomi-Clarke Issued 2,000,000 $0.066 $132,000 Issue of securities
21/12/16 Paul Hopper Sell +133,336 $0.092 ($12,267) As advised by the company
21/12/16 Steven (Steve) Engle Issued 370,000 $0.092 $34,040 Issue of options
21/12/16 Steven Yatomi-Clarke Issued 2,000,000 $0.094 $188,000 Issue of securities
21/12/16 James Campbell Issued 247,000 $0.092 $22,724 Issue of options
21/12/16 Paul Hopper Issued 247,000 $0.092 $22,724 Issue of options
08/11/16 Paul Hopper Buy +50,000 $0.10 $5,000 On-market trade
26/07/16 Paul Hopper Buy +40,000 $0.11 $4,400 On-market trade
30/06/16 Steven Yatomi-Clarke Issued 70,000 $0.088 $6,160 Rights issue
30/06/16 Paul Hopper Issued 22,222 $0.088 $1,956 Rights issue
30/06/16 Paul Hopper Issued 44,444 $0.09 $4,000 Rights issue
30/06/16 Steven Yatomi-Clarke Issued 140,000 $0.09 $12,600 Rights issue
07/12/15 Paul Hopper Buy +50,000 $0.093 $4,650 On-market trade
23/11/15 Steven (Steve) Engle Issued 300,000 $0.072 $21,600 Issue of options
23/11/15 James Campbell Issued 200,000 $0.072 $14,400 Issue of options
23/11/15 Steven Yatomi-Clarke Issued 200,000 $0.072 $14,400 Issue of options
23/11/15 Steven Yatomi-Clarke Buy +214,412 $0.054 $11,578 Participation in share purchase plan
23/11/15 Paul Hopper Buy +71,470 $0.054 $3,859 Participation in share purchase plan
22/06/15 Paul Hopper Issued 2,223,000 $0.067 $148,941 Issue of securities
22/06/15 Paul Hopper Issued 450,000 $0.067 $30,150 Issue of securities
22/06/15 Steven Yatomi-Clarke Issued 1,224,000 $0.067 $82,008 Issue of securities
11/12/14 Robert Crombie Issued 2,000,000 $0.13 $260,000 Issue of options
11/12/14 Paul Hopper Issued 4,366,671 $0.13 $567,667 Issue of securities
11/12/14 Paul Hopper Issued 216,667 $0.13 $28,167 Issue of securities
Show All

Director Interests

The current holdings of PTX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Allen Ebens 23/11/2024 N/A N/A 0 N/A
Steven (Steve) Engle 23/11/2024 219,939 N/A 0 N/A
Steven Yatomi-Clarke 23/11/2024 5,790,647 5,404,370 0 N/A
James Campbell 23/11/2024 396,365 N/A 0 N/A
Gavin Shepherd 30/09/2024 N/A 16,385,908 N/A N/A
Ellen Feigal 23/08/2024 N/A N/A 1,415,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 22, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Mr David Kenley 19,925,332 2.47%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 11,687,125 1.45%
Dr Gavin James Shepherd & Mrs Catherine Shepherd <Tpj Superannuation Fund A/C> 10,000,000 1.24%
Mr Andrew Morrison Stewart 9,233,176 1.15%
Citicorp Nominees Pty Limited 8,698,067 1.08%
Mr Richard Thomas Hayward Daly & Mrs Sarah Kay Daly <The Daly Family Super A/C> 7,000,000 0.87%
HSBC Custody Nominees (Australia) Limited 6,474,208 0.80%
Gavncath Pty Ltd <Shepherd Investment A/C> 6,150,000 0.76%
Mr Clinton Craig Hopper 6,093,595 0.76%
BNP Paribas Noms Pty Ltd 5,999,055 0.74%
Mr Anthony Graeme Halls & Mrs Simone Justine Halls <Ellalily Superfund A/C> 5,900,000 0.73%
Boycecorp Pty Ltd <Boycecorp Discretionary A/C> 5,809,400 0.72%
Mr Steven Yatomi-Clarke 5,790,647 0.72%
Dr Rosamund Julian Banyard & Mr Phillip Stanley Holten <R Banyard Super Fund A/C> 5,705,525 0.71%
Mr David Kenley <Kenley Super Plan A/C> 4,700,000 0.58%
Dossman Pty Ltd 4,682,077 0.58%
Mr Jakov Kulis 4,250,000 0.53%
Netwealth Investments Limited <Super Services A/C> 4,229,560 0.53%
Dr Vincent William Fitzgerald & Mrs Penelope Fitzgerald <Fitzgerald Super Fund A/C> 4,080,518 0.51%
Sb Investments Pty Ltd <Broadley Unit A/C> 3,333,928 0.41%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 2,538 722 794 2,709 1,310 8,073

Substantial Shareholders

No Substantial Shareholders for PTX in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.038 28 June
2023 $0.081 30 June
2022 $0.155 30 June
2021 $0.245 30 June
2020 $0.054 30 June
2019 $0.038 28 June
2018 $0.11 29 June
2017 $0.052 30 June
2016 $0.088 30 June
2015 $0.064 30 June
2014 $0.006 30 June
PTX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.